|
Contents
|
|
|
|
|
Embryonal
Tumors
|
|
|
|
H.
Shirato, J. Ikeda, H. Aoyama, N. Ishii, T. Taguchi, T. Kato, M. Tada, Y.
Sawamura
Low-dose
craniospinal irradiation and ifosfamide, cisplatine, and etoposide for embryonal
tumors in central nervous system
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
430
|
|
|
Germ
Cell Tumors
|
|
|
|
Kellie SJ,
Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL
Primary
chemotherapy for intracranial nongerminomatous germ cell tumors: results of the
second international CNS germ cell study group protocol
J Clin Oncol. 2004 Mar 1;22(5):846-53.
|
|
|
Gliomas
(Low-Grade)
|
|
|
|
|
Massimino
M, Spreafico F, Riva D, Biassoni V, Poggi G, Solero C, Gandola L, Genitori
L, Modena P, Simonetti F, Potepan P, Casanova M, Meazza C, Clerici CA,
Catania S, Sardi I, Giangaspero F
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood
progressive low-grade glioma
J
Neurooncol. 2010 Feb 12. [Epub ahead of print]
Abstract
|
Full
Text |
Reprint
|
|
|
Medulloblastoma
|
|
|
|
Khoshyomn S, Manske GC, Lew SM, Wald SL, Penar PL
Synergistic
action of genistein and cisplatin on growth inhibition and cytotoxicity of human
medulloblastoma cells
Pediatr Neurosurg 2000 Sep;33(3):123-31
|
|
Mothaffar
F Rimawi, Suleiman
Massarweh, Vu Ho, Uday Popat, Garrett R Lynch
Adult
cerebellar medulloblastoma at Ben Taub General Hospital
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No. 2110
|
|
|
Paulino AC, Mazloom A, Teh BS, South M, Okcu MF,
Su J, Butler EB, Chintagumpala M
Local
control after craniospinal irradiation, intensity-modulated radiotherapy
boost, and chemotherapy in childhood medulloblastoma
Cancer. 2010 Sep
15. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Saito R, Kumabe T, Sonoda Y, Kanamori M, Yamashita Y, Watanabe M, Tominaga
T.
Combination
chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma:
single-institute experience and differences in efficacy for subgroups of
medulloblastoma.
Childs
Nerv Syst. 2011 May 18. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Silvani A, Gaviani P, Lamperti E, Botturi A, Dimeco F, Franzini A, Ferroli
P, Fariselli L, Milanesi I, Erbetta A, Pollo B, Salmaggi A.
Adult medulloblastoma: multiagent chemotherapy with cisplatinum and
etoposide: a single institutional experience.
J Neurooncol.
2011 Aug 27. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Metastatic
Tumors
|
|
|
|
|
Christos Christodoulou,
Dimitrios Bafaloukos, Helen Linardou,
Gerassimos Aravantinos, Aristotelis Bamias,
Maria Carina, George Klouvas and
Dimosthenis Skarlos
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with
brain metastases from solid tumors: a Hellenic Cooperative Oncology
Group (HeCOG) Phase II study
Journal
of Neuro-Oncology, 71(1):
61-65, January 2005. (Abstract+)
|
|
Nasopharyngeal
Carcinoma
|
|
|
G.
Brandon Gunn, Ruben D. Villa, Ross R. Sedler, Fred Hardwicke, Gianluigi
A. Fornari, Rufus J. Mark
Nasopharyngeal
Carcinoma Metastasis to the Pituitary Gland: A Case Report and Literature
Review
Journal of Neuro-Oncology, 68 (1): 87-90, May 2004. (Abstract+)
|
|
Lung Cancer
|
|
|
D. Y. Kim, K. W. Lee, T. Yun,
J. H. Kim, D. W. Kim, S. A. Im, T. Y. Kim, D. S. Heo, Y. J. Bang, N. K. Kim
Efficacy of
platinum-based chemotherapy after cranial irradiation in patients with brain
metastasis from non-small cell lung cancer
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1575
|
|
Jane W. Marsh,
Maryann Donovan, Dennis R. Burholt, Lisa D. George and Paul L. Kornblith
Metastatic lung disease to the central nervous system: in
vitro response to
chemotherapeutic agents
Journal of Neuro-Oncology 66: 81–90, January
2004. (Abstract+)
|
|
|
Neuroblastoma
|
|
|
|
Elisabetta Donzelli, Maria
Carfì, Mariarosaria Miloso, Alberto Strada, Stefania Galbiati, Martine
Bayssas, Genevieve Griffon-Etienne, Guido Cavaletti, Maria Grazia
Petruccioli and Giovanni Tredici
Neurotoxicity of platinum
compounds: comparison of the effects of cisplatin and oxaliplatin on the
human neuroblastoma cell line SH-SY5Y
J Neurooncol. 2004 Mar-Apr;67(1-2):65-73. (Abstract+)
|
|
|
Tsuchida R, Das B, Yeger H, Koren G, Shibuya M,
Thorner PS, Baruchel S, Malkin D.
Cisplatin treatment increases survival and expansion of a highly
tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine
signaling
Oncogene. 2008 Jun 26;27(28):3923-34.
Epub 2008 Mar 10
Abstract
|
|
|
Non-Nervous
System T.
|
|
|
|
Kosty
MP, Fleishman SB, Herndon JE 2nd, Coughlin K, Kornblith AB, Scalzo A, Morris
JC, Mortimer J, Green MR
Cisplatin,
vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a
randomized placebo-controlled, double-blind phase III study of the Cancer and
Leukemia Group B
J Clin Oncol 1994 Jun;12(6):1113-20
|
|
Li D, Williams JI, Pietras RJ
Squalamine
and cisplatin block angiogenesis and growth of human ovarian cancer cells with
or without HER-2 gene overexpression
Oncogene 2002 Apr 25;21(18):2805-14
|
|
Scambia G, De Vincenzo R, Ranelletti
FO, Panici PB, Ferrandina G, D'Agostino G, Fattorossi A, Bombardelli
E,
Mancuso S
Antiproliferative
effect of silybin on gynaecological malignancies: synergism with
cisplatin and doxorubicin
Eur J Cancer. 1996
May;32A(5):877-82
|
|
|
Bokemeyer
C, Fels LM, Dunn T, Voigt W, Gaedeke J, Schmoll HJ, Stolte H,
Lentzen H
Silibinin
protects against cisplatin-induced nephrotoxicity without compromising
cisplatin or ifosfamide anti-tumour activity
Br J Cancer. 1996 Dec;74(12):2036-41
|
|
Pace A, Savarese A, Picardo M,
Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C, Jandolo B,
Cognetti F, Bove L
Neuroprotective
effect of vitamin e supplementation in patients treated with Cisplatin
chemotherapy
J Clin Oncol 2003 Mar 1;21(5):927-31
|
|
|
Oligoastrocytoma (Anapl.)
|
|
|
|
Boiardi A, Eoli M, Salmaggi A, Pollo
B, Milanesi I, Broggi G, Silvani A
Cisplatin and BCNU chemotherapy for
anaplastic oligoastrocytomas
J
Neurooncol 2000 Aug;49(1):71-5
|
|